Results 111 to 120 of about 57,565 (259)

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate

open access: yesHistopathology, EarlyView.
FOXA1 is a highly sensitive diagnostic marker for prostate cancer. Besides prostatic adenocarcinoma, it is also expressed in 57%–80% of metastatic or primary prostatic small cell carcinomas, which lose traditional prostatic markers including NKX3.1. Although it is less specific than NKX3.1, it can serve as a valuable adjunct for confirming prostatic ...
Jianping Zhao   +11 more
wiley   +1 more source

Multimodality Imaging Assessment of Malignant Pleural Mesothelioma

open access: yes, 2019
Malignant pleural mesothelioma (MPM) is officially recognized as an occupational neoplasm frequently diagnosed in an advanced stage. The disease is usually diffuse rather than focal, typically invasive.
Mazzei M. A.   +4 more
core   +1 more source

Erased by law: Kinship, care, and bureaucratic exclusion at the end of life in South Korea

open access: yesMedical Anthropology Quarterly, EarlyView.
Abstract This article examines how institutional frameworks in South Korea erase nonlegal caregiving relationships within hospice care environments. Drawing on seven months of ethnographic fieldwork, the study delineates how patients are categorized as “unclaimed” despite the presence of long‐term companions or cohabitants who provide intimate end‐of ...
Seok Joo Youn
wiley   +1 more source

Malignant mesothelioma in rare sites: two case reports

open access: yesFrontiers in Oncology
Mesothelioma is a rare tumor originating from mesothelial cells in the pleura or other sites. Malignant pleural mesothelioma (MPM) is the most common aggressive type of mesothelioma (accounting for 81%) and carries a poor prognosis (median OS: 1 year ...
Qiguang Du   +7 more
doaj   +1 more source

Environ Res [PDF]

open access: yes
Background:Malignant mesothelioma is associated with environmental and occupational exposure to certain mineral fibers, especially asbestos. This study aims to examine work histories of mesothelioma patients and their survival time.Method:Using the NIOSH

core  

Metastatic pleural mesothelioma presenting in a breast fine needle aspiration specimen

open access: yes, 2016
This is an unusual presentation of metastatic mesothelioma presenting as a breast lump and mimicking a primary tumour at that ...
Shield, P. W., Ribu, D. L.
core   +1 more source

Intravenous Bolus Fluid Therapy Versus No Fluid Therapy Prior to Pericardiocentesis in Dogs: A Randomized Controlled Trial in 30 Dogs

open access: yesJournal of Veterinary Emergency and Critical Care, EarlyView.
ABSTRACT Objective To determine the cardiovascular and respiratory effects of bolus IV isotonic crystalloid fluid therapy before pericardiocentesis in dogs with pericardial effusion. Design Prospective, randomized, nonblinded clinical trial (January 2021 to November 2022). Setting University teaching hospital.
Nadine Jones   +2 more
wiley   +1 more source

Pain management in patients with malignant mesothelioma: challenges and solutions

open access: yes, 2019
J Saunders,1 M Ashton,1,2 C Hall,3,4 B Laird,3,4 N MacLeod1 1Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK; 2Institute of Cancer Sciences, University of Glasgow, UK; 3Institute of Genetics and Molecular Medicine, University of Edinburgh ...
Laird B   +4 more
core  

Cancer heterogeneity explored through immune cell deconvolution of the tumor microenvironment

open access: yesQuantitative Biology, Volume 14, Issue 3, September 2026.
Abstract Cancer is a highly heterogeneous disease, characterized by significant variability across multiple dimensions. This diversity has been extensively studied from various perspectives. In this study, we aim to examine cancer heterogeneity through the lens of immune cell composition within the tumor microenvironment.
Limin Jiang   +4 more
wiley   +1 more source

Advances in the systemic therapy of malignant pleural mesothelioma.

open access: yes, 2008
Malignant pleural mesothelioma is an aggressive thoracic malignancy associated with exposure to asbestos, and its incidence is anticipated to increase during the first half of this century.
Fennell, D. A.   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy